Abstract
Aim: This study was planned to compare the extent of hypercoagulopathic complications in COVID-19 pneumonia with that of last year's pneumonia cases which consist of by other agents.
 Material and Method: The data of patients with pneumosepsis due to non-COVID-19 causes between 01 April-30 June 2019 and COVID-19 pneumosepsis patients between 01 April-30 June 2020,were analyzed retrospectively. Demographic data, comorbidities, SOFA scores, SIC scores, D-dimer levels, coagulopathic complications, mortality and discharge status of patients diagnosed with pneumosepsis and treated in both periods were recorded
 Results: While sequential D-dimer measurements did not show a significant change in the 2019 group, it was observed that it increased significantly in the 2020 group (p
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
